Global Coalition on Aging to Be Honored by American Federation for Aging Research

GCOA and AFAR Celebrate Innovation in Aging

NEW YORK CITY (April 15, 2013) – This evening Michael W. Hodin, PhD, executive director of the Global Coalition on Aging (GCOA), will receive the Fred D. Thompson Award of Distinction from the American Federation for Aging Research (AFAR) at AFAR’s Annual Awards Dinner in New York City.

The award, named in honor of the founding chairman of AFAR’s Board of Directors, is presented to individuals who have demonstrated an outstanding commitment to the field of aging research through activities and support of those involved in the field.

“It is a high honor to be recognized by the American Federation for Aging Research, an organization that is playing such a critical role in advancing our knowledge of and innovation around healthy aging,” said Hodin.  “I will proudly accept this award on behalf of all of the members, advisors and staff of the Global Coalition, who are so steadfastly committed to making aging a path for economic prosperity and personal wellbeing.”

Each year, AFAR recognizes the achievements of individuals and organizations whose work has impacted the field of aging research and improved public health.  For more than 30 years, AFAR has supported the science of healthier aging and advanced the knowledge base of age-related diseases by providing grants to support biomedical research of nearly 3,000 talented scientists.

“In just over two years, the Global Coalition on Aging, with its optimistic perspective and innovative approach to business and public policy, has helped place the spotlight on the opportunities of healthy aging,” said Stephanie Lederman, executive director of AFAR. “AFAR congratulates Mike Hodin and the Global Coalition on Aging for its leadership in advancing the global dialogue on population aging and looks forward to working together as we strive to meet our mutual goals.”

“Through Mike’s energy, enthusiasm and amazing networks, he has led the Global Coalition to become a real leader in the field of aging. It is incredible success for such a small organization to have achieved on such a crucial issue for our times,” said John Beard, Director of the Department of Ageing and Life Course at the World Health Organization.  “Our capacity to exert global influence on aging would be much less if Mike and the Global Coalition had not been such a close and supportive partner.”

This evening’s AFAR dinner will also honor Brian Daniels, MD, Senior Vice President, Global Development and Medical Affairs at Bristol-Myers Squibb and include a posthumous tribute to George Doty, a founding member of AFAR’s Board, and his wife Marie.

In conjunction with the AFAR Annual Awards Dinner, AFAR and GCOA are hosting an afternoon symposium titled “Innovation and the Future of Healthy Aging,” bringing together some of world’s leading business executives and academics driving changes centered on healthy aging.  Topics to be discussed include nutrition, technology and policy and investment.  Speakers include:

  • Richard W. Besdine, MD, AFAR Medical Officer and Professor of Medicine and of Health Services, Alpert Medical School of Brown University
  • Caroline Blaum, MD, Division of Geriatrics, New York University
  • Joseph Coughlin, Director, AgeLab, Massachusetts Institute of Technology
  • William Green, Director, Public Affairs & Relations, Nutricia (Danone)
  • Jennifer Grossman, Senior Vice President, Dole Nutrition Institute
  • Michael Hodin, Executive Director, Global Coalition on Aging
  • Shawn Morris, President of Development and Innovation, HealthSpring (Cigna)
  • Robert Romasco, President, AARP
  • Paul Simonetti, Consultant, Health & Wellness
  • Jack Watters, Vice President, External Medical Affairs, Pfizer

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.